AI Verdict
NGNE has stronger fundamentals based on our AI analysis.
NGVT vs NGNE Fundamental Comparison
| Metric | NGVT | NGNE |
|---|---|---|
| Revenue | $1.2B | $0.0 |
| Net Income | $-167.1M | $-90.4M |
| Net Margin | -14.3% | N/A |
| ROE | -562.6% | -34.1% |
| ROA | -10.1% | -31.3% |
| Current Ratio | 1.33x | 16.56x |
| Debt/Equity | 40.79x | 0.00x |
| EPS | $-4.61 | $-4.24 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
NGVT vs NGNE: Frequently Asked Questions
Is NGVT or NGNE a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), NGNE has stronger fundamentals. NGVT is rated SELL (78% confidence) while NGNE is rated SELL (85% confidence). This is not investment advice.
How does NGVT compare to NGNE fundamentally?
Ingevity Corp has ROE of -562.6% vs Neurogene Inc.'s -34.1%. Net margins are -14.3% vs N/A respectively.
Which stock pays higher dividends, NGVT or NGNE?
NGVT has a dividend yield of N/A or no dividend while NGNE has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in NGVT or NGNE for long term?
For long-term investing, consider that NGVT has SELL rating with 78% confidence, while NGNE has SELL rating with 85% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about NGVT vs NGNE?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For NGVT vs NGNE, the AI consensus favors NGNE based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.